Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence Force

The Australian Defence Force (ADF) has used mefloquine for malaria chemoprophylaxis since 1990. Mefloquine has been found to be a plausible cause of a chronic central nervous system toxicity syndrome and a confounding factor in the diagnosis of existing neuropsychiatric illnesses prevalent in the AD...

Descripción completa

Detalles Bibliográficos
Autor principal: McCarthy, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697095/
https://www.ncbi.nlm.nih.gov/pubmed/26793391
http://dx.doi.org/10.1155/2015/287651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697095/
https://www.ncbi.nlm.nih.gov/pubmed/26793391
http://dx.doi.org/10.1155/2015/287651

Ejemplares similares